Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity

Sandra Morel, Arnaud M. Didierlaurent, Patricia Bourguignon, +7

Vaccine

InflammationAllergyAdjuvant System As03α-Tocopherol ModulatesAdaptive Immune System +9

Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

Arnaud M. Didierlaurent, Catherine Collignon, Patricia Bourguignon, +10

The Journal of Immunology

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia, Catherine Collignon, Caroline Hervé, +18

npj Vaccines

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

Cheryl L. Day, Michèle Tameris, Nazma Mansoor, +19

American Journal of Respiratory and Critical Care Medicine

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen

Pascal Mettens, Patrice Dubois, Marie‐Ange Demoitié, +7

Vaccine

VaccinationT Cell ResponsesAdaptive Immune SystemNovel FormulationMalaria +10

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye, +46

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola Vaccine +6

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Isabel Leroux‐Roels, Marguerite Koutsoukos, Frédéric Clément, +10

Vaccine

VaccinationAdjuvant SystemsCandidate Hiv-1 VaccineHuman RetrovirusImmunology +8

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye, +43

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola Vaccine +5

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

Eva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, +8

Clinical Infectious Diseases

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

Sonia Budroni, Francesca Buricchi, Andrea Cavallone, +16

npj Vaccines